Related references
Note: Only part of the references are listed.Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator
Michael M. Jonczyk et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018)
Bo Pan et al.
CANCER MEDICINE (2019)
National trends of synchronous bilateral breast cancer incidence in the United States
Takehiko Sakai et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer
Charles E. Geyer et al.
NPJ BREAST CANCER (2018)
Molecular Genomic Testing for Breast Cancer: Utility for Surgeons
Oluwadamilola M. Fayanju et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer
Maria Karsten et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
Jeffrey G. Schneider et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Bilateral Breast Carcinoma: Clinical Characteristics and Its Impact on Survival
Hector D. Vuoto et al.
BREAST JOURNAL (2010)
Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays
Kathy S. Albain et al.
BREAST (2009)
The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer
Wenli Lu et al.
EUROPEAN JOURNAL OF CANCER (2009)
Incidence and prognosis of synchronous and Metachronous bilateral breast cancer
Mikael Hartman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours
AR Carmichael et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2002)